Dhanvantri Jeevan Rekha schedules board meeting for August 27

0 min read     Updated on 19 Aug 2026, 04:55 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Dhanvantri Jeevan Rekha Ltd will hold a board meeting on August 27, 2026, to discuss the AGM for FY26. The notice was filed with BSE under SEBI Listing Regulations. No financial results were disclosed in this procedural filing.

powered bylight_fuzz_icon
48684344

*this image is generated using AI for illustrative purposes only.

Dhanvantri Jeevan Rekha Ltd has scheduled a meeting of its Board of Directors for August 27, 2026. The primary purpose of the gathering is to consider the proposal for calling the company's Annual General Meeting (AGM) for the financial year ending 2026.

The board meeting is set to begin at 3:00 pm. The intimation was issued pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Ritika Bhandari, Company Secretary and Compliance Officer, signed the disclosure on August 19, 2026, from Meerut. The filing serves as formal notification to the Listing Department of BSE Limited.

The company operates Dhanvantri Hospital, a unit based in Meerut, Uttar Pradesh. The hospital holds NABH Pre Accredited status and is ISO 9001:2015 certified.

Historical Stock Returns for Dhanvantri Jeevan Rekha

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.41%+1.30%+16.16%+29.39%+170.07%

Will the upcoming AGM agenda include any proposals for dividend distribution or capital restructuring for FY2026?

How might the company's NABH Pre Accredited status influence its valuation or expansion plans in the competitive healthcare sector?

Are there any expected changes in the Board of Directors' composition or key management roles to be discussed at the August meeting?

Dhanvantri Jeevan Rekha
View Company Insights
View All News
like16
dislike

Dhanvantri Jeevan Rekha FY26 net profit falls 41.6% to ₹39 lakh

1 min read     Updated on 28 May 2026, 09:32 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Dhanvantri Jeevan Rekha Limited reported a 41.6% decline in net profit to ₹39 lakh for FY26, while revenue from operations increased 14.2% to ₹2,586 lakh. Total expenses rose to ₹2,579 lakh. The Board approved the audited financial results on May 28, 2026, and appointed M/s KPRS and Associates as internal auditor and M/s Sumit Bist & Associates as secretarial auditor. Statutory auditor Anuj Goyal & Co. issued an unmodified opinion, confirming adequate internal financial controls and no material pending litigations or defaults.

powered bylight_fuzz_icon
41528595

*this image is generated using AI for illustrative purposes only.

Dhanvantri Jeevan Rekha Limited reported a 41.6% decline in net profit to ₹39 lakh for the financial year ended March 31, 2026, down from ₹66 lakh in the previous year. The company's revenue from operations rose 14.2% to ₹2,586 lakh from ₹2,265 lakh in FY25, while total income increased to ₹2,619 lakh. Total expenses for the year stood at ₹2,579 lakh, up from ₹2,251 lakh in the prior year.

The Board of Directors, in its meeting held on May 28, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The meeting also approved the appointment of M/s KPRS and Associates as the internal auditor and M/s Sumit Bist & Associates as the secretarial auditor. The company declared an unmodified opinion on its standalone financial results for the period.

Financial Performance

For the quarter ended March 31, 2026, the company reported a net profit of ₹17 lakh, compared to ₹8 lakh in the corresponding quarter of the previous year. Revenue for the quarter stood at ₹724 lakh, while total expenses were ₹704 lakh. Earnings per share (EPS) for the year ended March 31, 2026, was ₹0.94, a decrease from ₹1.61 in the previous year.

Balance Sheet Highlights

The company's total assets increased to ₹1,757 lakh as of March 31, 2026, from ₹1,478 lakh a year earlier. Equity and liabilities stood at ₹1,757 lakh, with total equity at ₹1,051 lakh. Current liabilities rose to ₹550 lakh from ₹307 lakh in the previous year, while non-current liabilities decreased marginally to ₹156 lakh from ₹158 lakh.

Financial Metric (₹ in Lakhs) Year Ended 31.03.2026 Year Ended 31.03.2025
Net Sales / Income from Operations 2,586 2,265
Total Income 2,619 2,306
Total Expenses 2,579 2,251
Net Profit for the Period 39 66
Earnings Per Share (EPS) 0.94 1.61

Auditor's Report

Statutory auditor Anuj Goyal & Co. issued an unmodified opinion on the standalone financial statements, stating they give a true and fair view of the company's affairs. The auditor confirmed that the company has adequate internal financial controls over financial reporting which were operating effectively as of March 31, 2026. The report also noted that the company did not have any material pending litigations or defaults on borrowings during the year.

Historical Stock Returns for Dhanvantri Jeevan Rekha

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.41%+1.30%+16.16%+29.39%+170.07%

What specific factors drove the 41.6% decline in net profit despite a 14.2% increase in revenue?

How will the significant rise in current liabilities to ₹550 lakh impact the company's liquidity and working capital management?

What strategic initiatives does the company plan to implement to improve profit margins and EPS in the upcoming fiscal year?

Dhanvantri Jeevan Rekha
View Company Insights
View All News
like16
dislike

More News on Dhanvantri Jeevan Rekha

1 Year Returns:+29.39%